Label changes FDA suggests in a draft guidance to warn for skin reactions in acetaminophen-containing products should be proposed in a rulemaking to change the OTC monograph, the Consumer Healthcare Products Association says.
The trade group’s suggested process would mean that OTC acetaminophen product marketers would not be compelled to add label warnings for skin reactions until after a likely months- to years-long
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?